The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension

The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension

Currently available noninvasive markers for assessing disease severity and mortality risk in pulmonary arterial hypertension (PAH) are unrelated to fundamental disease biology. Endostatin, an angiostatic peptide known to inhibit pulmonary artery endothelial cell migration, proliferation and survival...

Full description

Bibliographic Details
Main Authors: Catherine E. Simpson, Megan Griffiths, Jun Yang, Melanie K. Nies, R. Dhananjay Vaidya, Stephanie Brandal, Lisa J. Martin, Michael W. Pauciulo, Katie A. Lutz, Anna W. Coleman, Eric D. Austin, D. Dunbar Ivy, William C. Nichols, Allen D. Everett, Paul M. Hassoun, Rachel L. Damico
Format: Article
Language:English
Published: European Respiratory Society 2021-10-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/7/4/00378-2021.full

Internet

http://openres.ersjournals.com/content/7/4/00378-2021.full

Similar Items